We are live on ! Find out more
CI

CPMG Inc Portfolio holdings

AUM $37.1M
1-Year Est. Return 74.35%
This Fund
S&P 500
This Quarter Est. Return
+25.65%
1 Year Est. Return
+74.35%
3 Year Est. Return
+878.37%
5 Year Est. Return
+1,872.39%
10 Year Est. Return
–
AUM
$398M
AUM Growth
-$112M
Cap. Flow
-$143M
Cap. Flow %
-36.02%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

1
APEN
Apollo Endosurgery, Inc.
APEN
+$16.6M

Top Sells

1
PRCT icon
Procept Biorobotics
PRCT
+$160M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRCT icon
1
Procept Biorobotics
PRCT
$1.09B
$221M 55.58%
5,328,867
-3,726,474
-41% -$160M
RETA
2
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$110M 27.63%
2,896,901
– –
APEN
3
DELISTED
Apollo Endosurgery, Inc.
APEN
$61.7M 15.48%
6,183,603
+2,219,962
+56% +$16.6M
TIL icon
4
Instil Bio
TIL
$50.9M
$5.18M 1.3%
410,923
– –

Similar funds

RH
Riverstone Holdings New York $36.9M AUM 80.85% 1-Year Est. Return
ICP
ION Crossover Partners Herzliya Pituach, Israel $36.9M AUM
GC
Gullane Capital Memphis, Tennessee $37.4M AUM 112.18% 1-Year Est. Return
PAWC
P.A.W. Capital Greenwich, Connecticut $36.7M AUM 6.81% 1-Year Est. Return
FC
Fiduciary Counselling Saint Paul, Minnesota $35.9M AUM 1.69% 1-Year Est. Return
BAM
BLKBRD Asset Management Old Greenwich, Connecticut $38.3M AUM 34.49% 1-Year Est. Return
CM
CoinFund Management New York $35.4M AUM
AP
Atairos Partners Bryn Mawr, Pennsylvania $35.2M AUM 32.88% 1-Year Est. Return

CPMG Inc's Q4 2022 Portfolio in Review

As of Q4 2022, CPMG Inc held 4 positions worth $398M, down 22% from $510M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

CPMG Inc withdrew a net $143M in Q4 2022, reducing 1 holding. Its largest reduction was Procept Biorobotics, cutting an estimated $160M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, CPMG Inc added an estimated $16.6M to Apollo Endosurgery, Inc..

  • CPMG Inc added most to Apollo Endosurgery, Inc. in Q4 2022, an estimated $16.6M increase.
  • CPMG Inc's biggest Q4 2022 reduction was Procept Biorobotics, cutting an estimated $160M.
  • CPMG Inc's ten largest holdings make up 100% of its $398M portfolio in Q4 2022.
  • CPMG Inc opened 0 new positions and closed 0 in Q4 2022.
  • CPMG Inc's portfolio value fell 22% quarter-over-quarter to $398M.

Based on CPMG Inc's 13F filing for Q4 2022, filed 14 Feb 2023.